Nexstim Bags Order for Navigated Brain Stimulation System in US
Nexstim (NXTMH.HE) secured an order for its Navigated Brain Stimulation 6 system from a US-based customer, according to a Friday release. The Finnish medical technology company said the client will use the device, which is approved for the treatment of major depressive disorder, for therapeutic applications.
Nexstim (NXTMH.HE) secured an order for its Navigated Brain Stimulation 6 system from a US-based customer, according to a Friday release.
The Finnish medical technology company said the client will use the device, which is approved for the treatment of major depressive disorder, for therapeutic applications.